🇺🇸United States·March 19, 2026·daily

S&P 500 Industrials Sector SEC Filings — March 19, 2026

Across 50 filings in the USA S&P 500 Industrials stream (broadly including transportation, construction, and adjacent sectors amid mixed data), overarching themes include robust revenue growth in transportation leaders like FedEx (+8% YoY Q3 to $24B) and strategic pivots (UPS prioritizing high-value volume), contrasted by widening losses in biotechs (Eledon +26% net loss YoY) and operational declines (Gemini trading volume -30% QoQ). Period-over-period trends show 12/50 companies with double-digit YoY revenue gains averaging +45% (e.g., argenx +90%, Eton +83% Q4), but 8 with margin compression or expense surges (avg +30-40% OpEx); adjusted EPS grew in outperformers like Darden (+5.4%) and FedEx (+16.4%). Capital allocation favors shareholder returns with 15+ dividend declarations (e.g., Global Net Lease prefs at coupon rates) and buybacks (GrowGen $10M, Darden $127M Q3). Proxy season dominates with 20+ DEF/DEFA14A filings clustering AGMs in May 2026, featuring governance votes and comp approvals. Forward-looking signals positive: FedEx raised FY26 guidance (rev 6-6.5%, EPS $19.30-20.10), Eton >$110M 2026 rev; risks from earnings delays (Armata) and trial postponements (Catalyst to May 18). Portfolio implication: overweight transportation (FedEx/UPS resilience), monitor biotech turnarounds, capitalize on May catalysts.

24 high priority26 medium50 total filings

🇺🇸United States·March 19, 2026·daily

S&P 500 Energy Sector SEC Filings — March 19, 2026

S&P 500 Energy sector filings from March 19, 2026, reveal a mix of proactive capital market access and shareholder governance activities, with Occidental Petroleum (OXY) dominating positive narratives through robust 2025 performance highlights including $10.5B operating cash flow, $4.3B free cash flow before working capital, $575M cost reductions, record production, and safety TRIR of 0.07 despite YoY challenging commodity prices. Cheniere Energy (LNG) signals strong liquidity via $1.75B senior notes issuance (5.200% due 2036, 6.000% due 2056), with registration rights underscoring structured debt management. Valero Energy (VLO) filings focus on standard proxy processes for its May 7 AGM, showing neutral sentiment and no financial trends disclosed. Aggregated period-over-period insights from OXY highlight debt reduction ($4B direct + $7B from OxyChem divestiture), resource base expansion to 16.5B BOE (up from 8B in 2015, +106%), and dividend growth (8%+ quarterly hike, +44% since 2023 CrownRock deal announcement), painting a picture of resilient capital allocation amid sector headwinds. Proxy season activation across OXY and VLO sets up near-term catalysts, while LNG's financing bolsters balance sheet for potential growth. No insider trading, guidance changes, or M&A details emerged, but positive sentiments from key filings (LNG/OXY) outpace neutrals, implying sector stability with pockets of outperformance.

3 high priority2 medium5 total filings

🇺🇸United States·March 19, 2026·daily

S&P 500 Financials Sector SEC Filings — March 19, 2026

Across 50 diverse SEC filings (despite 'S&P 500 Financials' stream label, spanning industrials, biotech, tech, mining, and limited true financials like BDCs/REITs), sentiment skews mixed with 14/50 positive, 16 mixed, and robust YoY revenue growth averaging +35% in 18 reporting companies (e.g., Micron +196%, Cardinal +45%, SUNation +26%) offset by declines in 6 (e.g., Solo Brands -30%, DarioHealth -17%). EBITDA/margin expansions prevalent in 12 cases (e.g., SUNation + to $2.5M, Aebi Schmidt Q4 +31%), but net losses widened in 10 biotechs/miners amid opex surges; cash strengthened in 15 (avg +40% YoY where trended). Capital allocation favors dividends (8 declarations steady, e.g., Chicago Atlantic BDC $0.34/share x6 quarters) and buybacks/debt paydowns (News Corp $1B program, SUNation debt -57%). M&A/SPAC activity high (RYVYL 99% merger support, Vine Hill EGM), proxy/AGMs cluster Q2 2026. Portfolio trends signal resilient growth amid costs, with BDC/REIT stability contrasting volatile small caps; actionable now: favor high-conviction growth like Micron/Accenture, monitor merger catalysts.

23 high priority27 medium50 total filings

🇺🇸United States·March 19, 2026·daily

S&P 500 Technology Sector SEC Filings — March 19, 2026

Across 20 S&P 500 Technology sector filings dated March 19, 2026, dominant themes include explosive revenue growth in semiconductors (Micron +196% YoY Q2 revenue to $23.9B) contrasted with modest IT services expansion (Accenture +8.3% YoY Q2 revenue) and revenue declines in niche tech (MultiSensor AI -25% YoY, Intuitive Machines -7.9% YoY), highlighting divergent performance amid cost discipline reducing losses portfolio-wide (e.g., Mustang Bio net loss -88% YoY, MultiSensor AI -46% YoY). Margin expansions in high-growth names like Micron (gross margin +499% YoY) offset compressions elsewhere (Planet Labs Q4 gross margin -800bps YoY to 54%), with positive forward guidance from Accenture (FY26 revenue 3-5% LC growth, raised) and Planet Labs (FY27 revenue $415-440M). Capital allocation leans shareholder-friendly via repurchases (Accenture treasury shares cost up to $11B), dividends (Palmer Square supplemental $0.01/share, Community Bancorp $0.25/share), and M&A (Intuitive Machines $800M acquisitions, dMY Squared quantum merger). Space tech shows momentum with contract wins and backlog surges (Planet RPOs +106% YoY to $852M, Intuitive backlog $943M), while neutral proxy filings signal routine governance. Portfolio-level trends point to 6/10 filings with revenue growth averaging +70% YoY in outperformers, but mixed sentiment (5 positive, 5 mixed) underscores selective opportunities in semis and space over softening software/services. Overall, bullish for high-conviction growth names with raised guidance, bearish for revenue decliners despite loss narrowing.

10 high priority10 medium20 total filings

🇺🇸United States·March 19, 2026·daily

Nasdaq 100 Stocks SEC Filings — March 19, 2026

Across 21 NASDAQ-100 related filings from March 19, 2026, dominant themes include explosive growth in semiconductors (Micron +196% YoY revenue) and AI/space sectors (Intuitive Machines $900M-$1B 2026 guidance), contrasted by revenue declines in sensor/AI holdings (MultiSensor -25% YoY) and persistent losses in metals/biotech (Lifezone net loss -$14.1M). Period-over-period trends show 7/21 companies with revenue growth >10% YoY (avg +150%), margin expansions in top performers (Micron gross margin +499% YoY), and widespread loss narrowing (Mustang Bio -88%, MultiSensor -46%). Balance sheets strengthened via financing (Intuitive Machines cash +181% to $582.6M, MultiSensor +459% to $24.4M), with capital allocation favoring debt reduction (Micron LT debt -32%) and dividends (Community Bancorp $0.25/share). Procedural filings (proxies, mergers) signal governance stability but low materiality. Portfolio-level, tech/AI outliers drive bullish sentiment (avg materiality 7/10), implying overweight in semis/space amid positive guidance and backlogs, while monitoring cash burn in pre-revenue explorers.

12 high priority9 medium21 total filings

🇺🇸United States·March 19, 2026·daily

Dow Jones 30 Stocks SEC Filings — March 19, 2026

Across 50 filings from the USA Dow Jones 30 intelligence stream (primarily smaller caps and blue-chips like UPS, CVS), a mixed sentiment prevails with 12/50 showing positive revenue/EBITDA growth (avg +40% YoY where reported, e.g., SOLV Energy +80% Q4 rev), contrasted by 8 cases of declines (avg -20% YoY rev/ARR) and debt stresses; healthcare/services outperform with 4/6 reporting +20%+ rev growth and margin expansion (e.g., Vericel 74% gross margin, +33% Adj EBITDA). Proxy statements dominate (14/50, mostly neutral, materiality 5/10 avg) signaling annual meeting season with May catalysts, while capital allocation leans defensive via dividends (6 declarations totaling ~$0.40-0.46/share quarterly). M&A activity peaks with 5 pending votes (RYVYL merger 99% in favor but adjourned; Vine Hill SPAC venue change) and deals like Aveanna's $175.5M acquisition. No widespread insider trading signals, but major holders noted in funds (GAMCO 9-10%). Forward guidance bullish for 7 cos (e.g., SOLV $3.72-3.82B 2026 rev +50% implied), building Q2 2026 catalysts; portfolio trend: growth outliers in space/health vs stressed balance sheets elsewhere.

29 high priority21 medium50 total filings

🇺🇸United States·March 19, 2026·daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 19, 2026

Across 50 SEC filings from the USA S&P 500 Consumer Discretionary stream (broadly encompassing retail, logistics, services), proxy season dominates with 20+ DEF 14A/DEFA14A filings for AGMs clustered in April-May 2026, emphasizing board elections, say-on-pay, and auditor ratifications amid neutral sentiment. Financial performance is polarized: standout YoY revenue growth in retail/logistics (Five Below +22.9% to $4.76B, FedEx Q3 +8% to $24B, Firefly Aerospace +163% to $159.9M) and industrials (Cardinal Infrastructure +45% to $456M, York Space +52% to $386M), contrasted by declines (FiscalNote FY25 -21% to $95.4M, Crawford -2.3% to $1.31B) and widening losses (Larimar Q4 $62.5M vs prior $28.8M). Capital allocation trends positive with buybacks (Aflac $3.5B/33M shares, Crawford $10.5M up from $3.9M), dividend hikes (Aflac +5.2% to $0.61 Q1 2026, Crawford +3.6% to $0.29), and debt reductions (Crawford -24.8% to $151M, Wolfspeed refinancing $475.9M higher-cost notes). Forward guidance largely raised/affirmed (FedEx FY26 rev growth to 6-6.5%, Firefly $420-450M, Cardinal 20%+ EBITDA margin), signaling resilience in consumer demand despite margin pressures (e.g., Cardinal gross margin -80bps to 14%). M&A/JV activity bullish (UniFirst-Cintas merger, Horizon $100M JV), with no notable insider transactions but major holders like GAMCO/Saba in funds. Portfolio-level: 8/15 key financial filers show >20% rev growth avg +60%, but 5 report margin compression avg -100bps; actionable now on catalysts like FedEx spin-off.

27 high priority23 medium50 total filings

🇺🇸United States·March 19, 2026·daily

S&P 500 Healthcare Sector SEC Filings — March 19, 2026

Across 45 filings in the USA S&P 500 Healthcare stream, biotech and healthcare firms (e.g., Assembly, SELLAS, Humacyte, Inhibrx) dominate with narrowed net losses (avg -20% YoY across 6 biotechs) amid R&D ramps (+16% avg YoY) and key partnerships like Gilead's $35M HPI license to Assembly, but cash burns persist requiring shelf registrations and offerings. Broader filings reveal mixed revenue trends (+1.6% YoY sales at Signet, -5.5% at RCI Hospitality) with margin expansions in retail (Signet +130 bps op margin) contrasting biotech pressures; capital returns strong via dividend hikes (Signet +20% to $0.35, Occidental +8% quarterly) and buyback expansions (News Corp $1B, Niagen to $20M). Clinical catalysts abound in healthcare (SELLAS REGAL 72/80 events, Humacyte Symvess launch), signaling near-term alpha, while non-healthcare financials show proxy governance focus. Portfolio-level: 12/45 filings with YoY revenue growth (avg +25% in biotechs), but 8/45 with SSS declines (avg -3.5%); sentiment mixed/neutral (70%), with healthcare bullish on trials/partners. Implications: Favor biotechs with milestones and cash runway >2yrs; monitor Nasdaq risks and Q2 catalysts for healthcare outperformance vs broader market weakness.

25 high priority20 medium45 total filings

🇺🇸United States·March 18, 2026·daily

S&P 500 Consumer Staples Sector SEC Filings — March 18, 2026

Across 50 filings in the USA S&P 500 Consumer Staples stream (with broader exposure via related filings), proxy statements dominate, signaling peak AGM season in Q2 2026 with 10+ meetings (e.g., Wells Fargo April 28, Primo Brands April 28, Piedmont May 12), emphasizing governance and compensation votes amid stable sector backdrop. Financial reporters show robust revenue growth averaging ~30% YoY (e.g., Accelerant +51.5%, Five Below +22.9% FY25, Envela +33.6%), driven by expansion and M&A, but mixed profitability with margin compressions (Envela -220 bps, PGIM yield -122 bps) and swing losses (Accelerant -$1.35B). Staples highlights include General Mills earnings release and McCormick controller transition (neutral), while Primo Brands post-merger proxy underscores beverage stability. M&A/capital activity surges (FingerMotion acquisition, Energy Fuels ASM deal, Accelerant $200M buyback), but dilution risks in microcaps (Artelo bridge notes, ECD notes). Portfolio trends: 7/12 metric-rich filings report YoY revenue acceleration vs flat/decline in laggards like Actelis (-53%), positioning outperformers for catalysts. Implications: favor growth names with guidance (Five Below FY26 $5.2-5.3B sales), monitor proxies for comp changes, avoid dilution traps.

28 high priority22 medium50 total filings

🇺🇸United States·March 18, 2026·daily

S&P 500 Industrials Sector SEC Filings — March 18, 2026

Across 50 filings from diverse sectors (heavy in financials despite Industrials focus), overarching themes include robust M&A activity in banking (e.g., Heritage Commerce merger supplements, Independent Bank $70M deal 6% accretive), mixed financial performance with revenue growth in outliers like Tecogen (+19.7% YoY to $27M) and Hills Bancorp (assets +4.5%, net income +27.1%), but margin pressures (Tecogen gross margins -730bps to 36.3%, Home Depot operating income -2.9%). Period-over-period trends show YoY revenue growth averaging ~10% in reporting firms (e.g., Spire FY25 $71.6M, Tecogen +20%), NIM expansions in banks (+67bps at Hills), but widening losses (Tecogen net loss +73% to $8.25M Q4) and flat incomes (Golden Growers +0.3%). Capital allocation leans toward dividends (Great Southern $0.43/share), debt extensions (Hilton RCf maturity extended), and equity issuances for M&A/growth. Critical developments: Advancing acquisitions (Great Lakes HSR cleared), positive guidance (Spire FY26 rev $75-85M, +41-61% ex-maritime), and leadership stability awards (Eagle Bancorp $1.175M continuity pay). Portfolio-level: Industrials subset shows resilient growth amid macro volatility, with M&A catalysts driving near-term upside but litigation risks in deals.

28 high priority22 medium50 total filings

🇺🇸United States·March 18, 2026·daily

S&P 500 Energy Sector SEC Filings — March 18, 2026

Across the six S&P 500 Energy stream filings (including contextual non-core like XOMA Royalty and Williams-Sonoma), key themes include robust capital allocation via dividends and buybacks, mixed financial performance with standout revenue growth in XOMA Royalty (+83% YoY to $52.1M) and Williams Companies (Adjusted EBITDA +9% YoY to $7.75B), contrasted by revenue declines at Williams-Sonoma (-4.2% YoY Q4 FY25). Period-over-period trends show strong YoY improvements in profitability for XOMA (net income $31.7M vs $13.8M loss) and operational expansions at Williams (12 growth projects completed, 10 announced), while Phillips 66 bolsters liquidity with a $2.25B term loan. Forward-looking catalysts cluster in 2026, including XOMA's Phase 2b volixibat data (Q2) and Phase 3 ersodetug (2H), Williams-Sonoma FY26 comps guidance (+2-6%), and Williams AGM on April 28. Energy-focused filers (Phillips 66, Williams) signal financial strength and growth conviction amid sector midstream/refining stability, but mixed sentiments highlight pipeline risks and margin pressures. Portfolio-level, 3/6 filings show dividend hikes (Williams +5%, Williams-Sonoma +15%), underscoring shareholder returns prioritization over reinvestment.

3 high priority3 medium6 total filings

🇺🇸United States·March 18, 2026·daily

S&P 500 Financials Sector SEC Filings — March 18, 2026

Across 50 SEC filings in the USA S&P 500 Financials intelligence stream (including banks, REITs, insurers, and adjacent sectors), overarching themes include robust capital returns via dividends (e.g., Great Southern Bancorp $0.43/share Q1 2026) and buybacks (Vistra $5.75B since 2021, NRG $1.65B), ongoing M&A activity in financials marred by shareholder litigation (Heritage-CVB merger supplements for 3 suits ahead of Mar 26 votes), and proxy approvals for governance amid neutral sentiment. Period-over-period trends reveal mixed revenue performance: 8/20 detailed reporters showed YoY growth averaging +38% (outliers TSS +66%, Bob's +16.8%), but 6 reported declines averaging -10% (Macy's -2.4% FY sales, Harte Hanks -13.9%), with margin compressions in 5/12 cases (-40bps avg, e.g., Macy's gross margin). Financials-specific patterns highlight REIT proxy focus on sustainability/insider policies (Seven Hills, ILPT) and bank merger risks, while forward-looking guidance flags upside (Protalix rev $78-83M 2026, Macy's Adj EPS $1.90-2.10). Critical developments: Strong 2025 beats (NRG EBITDA 167% target, Vistra Adj EBITDA +$112M), but going concern risks (Stardust $3.5M cash) imply selective opportunities in dividend payers and buyback leaders. Portfolio implications: Overweight financials with returns focus (avg dividend/buyback yield implied +5-7%), monitor Mar 26 bank votes for deal risks.

26 high priority24 medium50 total filings

🇺🇸United States·March 18, 2026·daily

S&P 500 Technology Sector SEC Filings — March 18, 2026

Across these 10 filings from the S&P 500 Technology stream (broadly including software, blockchain, semis, and adjacent), Micron Technology dominates with record Q2 FY2026 revenue of $23.86B (+75% QoQ, +196% YoY) and raised Q3 guidance to $33.5B ±$0.75B at 81% margins, signaling robust semiconductor demand. Contrasting sharply, dMY Squared reported widened net losses to $17.8M YoY amid surging G&A (+310%) and ballooning liabilities (+268% YoY), highlighting SPAC unwind risks. M&A and restructuring themes emerge with RocketFuel's non-binding asset sale term sheet retaining cash reserves, BlockchAIn's completed business combo unlocking AI/HPC data center revenue ($22.9M in 2024), and Creative Media's massive 261M+ share dilution for preferred redemptions. Capital allocation leans positive with Micron's 30% dividend hike to $0.15/share (record date March 30, 2026), while equity grants to ACNB execs and board elections/stability at Pineapple and ImmuCell add low-materiality positives. Period-over-period trends show 1/10 with explosive growth (Micron), 1/10 with sharp deterioration (dMY), and neutral restructuring in 3/10; no broad insider selling patterns, but interested-party transactions flagged. Sector implications point to AI/semiconductor strength amid blockchain/AI infra deals, but dilution and loss-making entities pressure smaller tech names.

7 high priority3 medium10 total filings

🇺🇸United States·March 18, 2026·daily

Nasdaq 100 Stocks SEC Filings — March 18, 2026

Across 11 NASDAQ-100 related filings, standout performance from Micron Technology with record Q2 FY2026 revenue up 75% QoQ ($13.64B to $23.86B) and 196% YoY ($8.05B), driving 74.4% GAAP gross margins (up from 36.8% YoY) and a 30% dividend hike to $0.15/share, signaling robust semiconductor demand amid AI boom. Biotech and metals sectors show clinical and operational progress (MetaVia Phase 1 approval, ImmuCell board addition, Welsbach video), while Faraday Future's $500k employee share repurchase aligns management with shareholders. Dilution risks emerge in Creative Media & Community Trust's issuance of over 261M common shares for preferred redemptions, potentially pressuring stock price. Neutral shelf registrations (Critical Metals F-3) and governance updates (Pineapple, Community Trust) indicate routine capital access and stability. Portfolio-level trends reveal margin expansion outliers in semis (Micron +3,760 bps YoY gross margin) contrasting dilution in REITs; forward catalysts cluster in Q2-Q4 2026 for biotech data and dividends. Overall, bullish tech/semiconductor momentum outweighs dilution and neutral fundraising themes, with actionable buys in high-growth leaders.

3 high priority8 medium11 total filings

🇺🇸United States·March 18, 2026·daily

Dow Jones 30 Stocks SEC Filings — March 18, 2026

Across 50 SEC filings from the USA Dow Jones 30 intelligence stream (March 18, 2026 period), overarching themes include robust revenue growth in energy (Vistra exceeding EBITDA guidance by $112M, Energy Vault +341% YoY to $203.7M) and select retail/biotech sectors, contrasted by widespread margin compression (e.g., Home Depot operating income -2.9% YoY, Bob's Discount gross margin -110 bps to 45.7%) and persistent net losses in 12+ companies despite top-line gains. Portfolio-level trends show 18/50 filings with YoY revenue acceleration (avg +45% in high-growers like Accelerant +51.5%), but 15 report widening losses or equity erosion (e.g., Natural Resource net loss +2-6% YoY, cash at $0); capital returns remain strong with $5.75B Vistra buybacks since 2021 and dividends in banks like Great Southern $0.43/share. Critical developments: Biotech catalysts (Arvinas Phase 1 success >50% LRRK2 degradation), M&A progress (Two Harbors-UWM), and dilution risks (Creative Media 261M shares issued). Market implications favor energy/utilities outperformance amid strategic PPAs/acquisitions, while retail faces transaction declines (Home Depot -2.2% customers YoY); blue-chip stability via credit extensions (Hilton) signals resilience, but watch governance shifts and exec transitions in 10+ firms for conviction gauges.

33 high priority17 medium50 total filings

🇺🇸United States·March 18, 2026·daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 18, 2026

Across 50 SEC filings from S&P 500 Consumer Discretionary and related streams, overarching themes include modest revenue growth in retail (e.g., Five Below +22.9% YoY, Bob's Discount +16.8% YoY, Home Depot +3.2% YoY) offset by widespread margin compression (e.g., Bob's gross margin -110 bps to 45.7%, Home Depot ROIC -570 bps to 25.7%) and mixed profitability trends, with 7/12 key financial reporters showing net income improvements averaging +45% YoY but operating losses in high-growth names like HeartFlow (-$117M). Capital allocation leans toward debt expansions (Hilton RCF extension, Hyperfine $40M facility) and M&A (RocketFuel asset sale, FingerMotion Telforge acquisition), signaling liquidity management amid volatility. Forward-looking guidance is optimistic in retail (Five Below FY26 sales $5.20-5.30B, comp +3-5%) but cautious on cash burn (Hyperfine $26-28M). Portfolio-level patterns reveal 6/10 retail filings with comp sales acceleration (avg +10% YoY) but inventory builds (Home Depot +10%, Bob's +15%) hinting demand risks. Neutral sentiment dominates (28/50 filings), with positive financing/M&A catalysts and proxy season ramp-up offering near-term volatility. Critical implications: Favor high-comp growth like Five Below over decelerating giants like Home Depot; monitor Q1 FY26 guidance for margin recovery.

30 high priority20 medium50 total filings

🇺🇸United States·March 18, 2026·daily

S&P 500 Healthcare Sector SEC Filings — March 18, 2026

Across the 33 filings in the USA S&P 500 Healthcare stream (with broader cross-sector context), healthcare firms show mixed performance: service providers like Pacific Health Care Organization achieved +11% YoY revenue and +57% net income growth, while device/biotech players like Lifeward (-14% FY revenue) and Cingulate (+35% net loss YoY) faced headwinds amid Nasdaq compliance risks (e.g., CalciMedica) and funding needs (Artelo Biosciences bridge notes). Financial peers (non-core but contextual) displayed resilient net income growth averaging +55% YoY (Sound Financial +54%, AmeriServ +56%) with NIM expansions (+45bps to +34bps), contrasting healthcare's revenue declines in 3/7 key firms averaging -14%. Proxy season ramps up with healthcare giants like Boston Scientific filing DEFA14A/DEF14A, signaling governance focus; capital allocation leans conservative (e.g., First Financial $0.56 dividend). Forward catalysts cluster in H1 2026, including Cingulate's PDUFA May 31 and CalciMedica compliance deadlines Sep 2026. Portfolio implication: favor healthcare services over devices/biotech amid volatility, monitor small-cap delisting risks.

18 high priority15 medium33 total filings

🇺🇸United States·March 17, 2026·daily

S&P 500 Consumer Staples Sector SEC Filings — March 17, 2026

Across 50 filings in the USA S&P 500 Consumer Staples intelligence stream (with broader equity exposure), mixed financial results dominate, with 12/50 showing YoY revenue growth averaging +25% driven by acquisitions (e.g., Intelligent Protection +2050%, ClearPoint +18%), offset by declines in 8/50 averaging -20% (e.g., Telesat -26.8%, Skkynet -34%). Margin compression is evident in 7/15 detailed financials (avg -200 bps, e.g., lululemon -260 bps), while gross margins held steady in others like ClearPoint at 61%. Capital allocation trends favor buybacks (Coca-Cola Europacific 356k shares) and redemptions (Wells Fargo Series BB), with M&A active (Brookfield $2B acquisitions, ClearPoint IRRAS). Forward-looking catalysts include ClearPoint's 2026 revenue guide $52-56M (+42% midpoint), Monte Rosa cash to 2029, and SPAC extensions (Pelican, Israel Acquisitions to Apr 2026). Board enhancements signal conviction (lululemon Chip Bergh, Peloton Sarah Robb O’Hagan), but biotech/consumer names like lululemon show regional divergences (China +29% vs Americas -1%). Portfolio implication: Favor acquisition-driven growers amid margin pressures; monitor SPAC redemptions and Q1 guidance.

33 high priority17 medium50 total filings

🇺🇸United States·March 17, 2026·daily

S&P 500 Industrials Sector SEC Filings — March 17, 2026

Across 50 SEC filings from the USA S&P 500 Industrials stream (March 17, 2026), dominant themes include accelerating bank M&A with regulatory approvals for UBFO/CWBC and Mechanics/HomeStreet mergers driving asset/deposit growth (e.g., +36% YoY) but offset by NIM compression (Bank7 -17bps, Mechanics +12bps mixed) and rising provisions; explosive revenue surges post-acquisitions (INTELLIGENT PROTECTION +2050% YoY to $23.6M, Phoenix Energy +144% to $687M); SPAC distress with extensions (AlphaTime trust down to $4.8M from heavy redemptions) and LOIs for financing. Period-over-period trends reveal mixed revenue growth (8/20 financials showed +10-800% YoY boosts from deals, 6 declined >10%), margin pressures (Urban One EBITDA -38%, Bank7 NIM -17bps), but positive guidance in industrials (Andersen +14-15% rev FY26, Phoenix 15.5-16.8M Boe). Capital allocation leans shareholder-friendly (dividends at First Guaranty 131st consecutive, buybacks at New Peoples 500k shares, IZEA $10M program); 15+ proxy filings signal Q2 governance catalysts. Implications: Favor M&A beneficiaries and high-growth acquirers amid sector consolidation, monitor SPAC deadlines and delistings like Urgent.ly.

30 high priority20 medium50 total filings

🇺🇸United States·March 17, 2026·daily

S&P 500 Energy Sector SEC Filings — March 17, 2026

The three filings in the USA S&P 500 Energy intelligence stream highlight divergent paths: two positive 425 filings on AParadise Acquisition Corp.'s $1.3B SPAC merger with Enhanced Games (sports innovation with PEDs under medical supervision), signaling bullish investor interest via Accelerate Arbitrage Fund's long position, contrasted by Idaho Copper Corp.'s mixed 10-K showing pre-revenue status with zero revenue FY2026 vs FY2025, 44% YoY operating expense decline to $2.6M, and 40% net loss improvement to $3.1M, but critically low cash at $24K (down from $101K) and widening stockholders' deficit to $6.5M. Period-over-period trends reveal cost discipline at Idaho (professional fees -39%, stock-based comp -51%, rent -89%) amid liquidity erosion, with no revenue growth across filings underscoring pre-commercial stages. Key developments include Enhanced Games' May 2026 Las Vegas debut and Abu Dhabi training, positioning AParadise for catalysts, while Idaho's stable $3.13M bond liabilities and $2.31M accrued interest flag balance sheet risks. Portfolio-level patterns show innovation-driven SPAC optimism vs resource extraction distress, with positive sentiment dominating (2/3 filings) but materiality highest for Idaho (9/10). Market implications favor event-driven plays in AParadise amid energy transition themes (e.g., athlete health tech parallels), while urging caution on Idaho's near-term survival.

3 high priority3 total filings